Editor’s Note: This article originally appeared on Abbott’s website. ABBOTT PARK, Ill., May 31, 2018 /PRNewswire/ — Abbott (NYSE: ABT) announced today the launch of its Afinion™ 2 analyzer in the U.S.

Abbott ABT recently announced the launch of the latest generation of the Afinion test system — Afinion 2 analyzer — in the United States. This system delivers accurate hemoglobin A1c (HbA1c) results ...

Abbott announced that its Afinion™ HbA1c Dx assay is now available for use on the Afinion 2 Analyzer, as well as the Afinion AS100 Analyzer. The product is the first and only rapid point-of-care test ...

Diagnostics manufacturer Abbott recently announced FDA clearance of the Afinion HbA1c Dx assay for use with the Afinion™ AS100 Analyzer. The assay is the first-ever rapid point-of-care test approved ...

NICE has developed a medtech innovation briefing (MIB) on the Alere Afinion CRP for C-reactive protein testing in primary care. MIBs provide a description of the medical technology, including its ...

Abbott announced that its Afinion HbA1c Dx assay is now available for use on the Afinion 2 Analyzer, as well as the Afinion AS100 Analyzer. The Afinion HbA1c Dx assay is the first and only rapid point ...

Although the company saw strong sales of its Afinion machine, used by physicians to test for diabetes and other conditions, higher marketing costs contributed to a 32 per cent fall in pre-tax profit ...

The Afinion 2 platform also provides all-in-one connectivity to laboratory and hospital information systems (LIS/HIS), which enables healthcare providers to use it in various out-patient settings. Per ...

The specialist commentators reflected that the Alere Afinion CRP test may produce cost savings through fewer follow-up appointments in primary care, less unnecessary A&E attendance, and by improving ...

AbbottABT recently announced the launch of the latest generation of the Afinion test system - Afinion 2 analyzer - in the United States. This system delivers accurate hemoglobin A1c (HbA1c) results in ...